Eli Lil­ly seeks to join law­suit over end of tirzepatide short­age

Eli Lil­ly has asked to in­ter­vene in lit­i­ga­tion be­tween a com­pound­ing phar­ma­cy trade group and the FDA over the agency’s de­ci­sion to re­move Lil­ly’s block­buster …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.